Pharma & Healthcare
Global Oral Voriconazole Market Research Report 2026
- Mar 14, 26
- ID: 729502
- Pages: 119
- Figures: 119
- Views: 6
This report delivers a comprehensive overview of the global Oral Voriconazole market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Voriconazole. The Oral Voriconazole market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oral Voriconazole market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Voriconazole manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Sandoz
Sun Pharmaceutical
Teva
Taj Pharmaceuticals
SiNi Pharma
Lupin Pharmaceuticals
Viona Pharmaceuticals
Yangzijiang Pharmaceutical Group
Huahai Pharmaceutical
Beijing Genetech Pharmaceutical
Union-Bio science
Brilliant Pharmaceuticals
Zhuhai Rundu Pharmaceutical
Poly Pharm
Segment by Type
Voriconazole Tablets
Voriconazole Capsules
Voriconazole Suspension
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oral Voriconazole companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Oral Voriconazole market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Voriconazole manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Sandoz
Sun Pharmaceutical
Teva
Taj Pharmaceuticals
SiNi Pharma
Lupin Pharmaceuticals
Viona Pharmaceuticals
Yangzijiang Pharmaceutical Group
Huahai Pharmaceutical
Beijing Genetech Pharmaceutical
Union-Bio science
Brilliant Pharmaceuticals
Zhuhai Rundu Pharmaceutical
Poly Pharm
Segment by Type
Voriconazole Tablets
Voriconazole Capsules
Voriconazole Suspension
Segment by Application
Hospital Pharmacy
Retail Pharmacy
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oral Voriconazole companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Voriconazole Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Voriconazole Tablets
1.2.3 Voriconazole Capsules
1.2.4 Voriconazole Suspension
1.3 Market by Application
1.3.1 Global Oral Voriconazole Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Voriconazole Market Perspective (2021–2032)
2.2 Global Oral Voriconazole Growth Trends by Region
2.2.1 Global Oral Voriconazole Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oral Voriconazole Historic Market Size by Region (2021–2026)
2.2.3 Oral Voriconazole Forecasted Market Size by Region (2027–2032)
2.3 Oral Voriconazole Market Dynamics
2.3.1 Oral Voriconazole Industry Trends
2.3.2 Oral Voriconazole Market Drivers
2.3.3 Oral Voriconazole Market Challenges
2.3.4 Oral Voriconazole Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Voriconazole Players by Revenue
3.1.1 Global Top Oral Voriconazole Players by Revenue (2021–2026)
3.1.2 Global Oral Voriconazole Revenue Market Share by Players (2021–2026)
3.2 Global Top Oral Voriconazole Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oral Voriconazole Revenue
3.4 Global Oral Voriconazole Market Concentration Ratio
3.4.1 Global Oral Voriconazole Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Voriconazole Revenue in 2025
3.5 Global Key Players of Oral Voriconazole Head Offices and Areas Served
3.6 Global Key Players of Oral Voriconazole, Products and Applications
3.7 Global Key Players of Oral Voriconazole, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oral Voriconazole Breakdown Data by Type
4.1 Global Oral Voriconazole Historic Market Size by Type (2021–2026)
4.2 Global Oral Voriconazole Forecasted Market Size by Type (2027–2032)
5 Oral Voriconazole Breakdown Data by Application
5.1 Global Oral Voriconazole Historic Market Size by Application (2021–2026)
5.2 Global Oral Voriconazole Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oral Voriconazole Market Size (2021–2032)
6.2 North America Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oral Voriconazole Market Size by Country (2021–2026)
6.4 North America Oral Voriconazole Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Voriconazole Market Size (2021–2032)
7.2 Europe Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oral Voriconazole Market Size by Country (2021–2026)
7.4 Europe Oral Voriconazole Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oral Voriconazole Market Size (2021–2032)
8.2 Asia-Pacific Oral Voriconazole Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oral Voriconazole Market Size by Region (2021–2026)
8.4 Asia-Pacific Oral Voriconazole Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oral Voriconazole Market Size (2021–2032)
9.2 Latin America Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oral Voriconazole Market Size by Country (2021–2026)
9.4 Latin America Oral Voriconazole Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Voriconazole Market Size (2021–2032)
10.2 Middle East & Africa Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oral Voriconazole Market Size by Country (2021–2026)
10.4 Middle East & Africa Oral Voriconazole Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Voriconazole Introduction
11.1.4 Pfizer Revenue in Oral Voriconazole Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Sandoz
11.2.1 Sandoz Company Details
11.2.2 Sandoz Business Overview
11.2.3 Sandoz Oral Voriconazole Introduction
11.2.4 Sandoz Revenue in Oral Voriconazole Business (2021–2026)
11.2.5 Sandoz Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Oral Voriconazole Introduction
11.3.4 Sun Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Oral Voriconazole Introduction
11.4.4 Teva Revenue in Oral Voriconazole Business (2021–2026)
11.4.5 Teva Recent Development
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Company Details
11.5.2 Taj Pharmaceuticals Business Overview
11.5.3 Taj Pharmaceuticals Oral Voriconazole Introduction
11.5.4 Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.5.5 Taj Pharmaceuticals Recent Development
11.6 SiNi Pharma
11.6.1 SiNi Pharma Company Details
11.6.2 SiNi Pharma Business Overview
11.6.3 SiNi Pharma Oral Voriconazole Introduction
11.6.4 SiNi Pharma Revenue in Oral Voriconazole Business (2021–2026)
11.6.5 SiNi Pharma Recent Development
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Details
11.7.2 Lupin Pharmaceuticals Business Overview
11.7.3 Lupin Pharmaceuticals Oral Voriconazole Introduction
11.7.4 Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.7.5 Lupin Pharmaceuticals Recent Development
11.8 Viona Pharmaceuticals
11.8.1 Viona Pharmaceuticals Company Details
11.8.2 Viona Pharmaceuticals Business Overview
11.8.3 Viona Pharmaceuticals Oral Voriconazole Introduction
11.8.4 Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.8.5 Viona Pharmaceuticals Recent Development
11.9 Yangzijiang Pharmaceutical Group
11.9.1 Yangzijiang Pharmaceutical Group Company Details
11.9.2 Yangzijiang Pharmaceutical Group Business Overview
11.9.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Introduction
11.9.4 Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2021–2026)
11.9.5 Yangzijiang Pharmaceutical Group Recent Development
11.10 Huahai Pharmaceutical
11.10.1 Huahai Pharmaceutical Company Details
11.10.2 Huahai Pharmaceutical Business Overview
11.10.3 Huahai Pharmaceutical Oral Voriconazole Introduction
11.10.4 Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.10.5 Huahai Pharmaceutical Recent Development
11.11 Beijing Genetech Pharmaceutical
11.11.1 Beijing Genetech Pharmaceutical Company Details
11.11.2 Beijing Genetech Pharmaceutical Business Overview
11.11.3 Beijing Genetech Pharmaceutical Oral Voriconazole Introduction
11.11.4 Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.11.5 Beijing Genetech Pharmaceutical Recent Development
11.12 Union-Bio science
11.12.1 Union-Bio science Company Details
11.12.2 Union-Bio science Business Overview
11.12.3 Union-Bio science Oral Voriconazole Introduction
11.12.4 Union-Bio science Revenue in Oral Voriconazole Business (2021–2026)
11.12.5 Union-Bio science Recent Development
11.13 Brilliant Pharmaceuticals
11.13.1 Brilliant Pharmaceuticals Company Details
11.13.2 Brilliant Pharmaceuticals Business Overview
11.13.3 Brilliant Pharmaceuticals Oral Voriconazole Introduction
11.13.4 Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.13.5 Brilliant Pharmaceuticals Recent Development
11.14 Zhuhai Rundu Pharmaceutical
11.14.1 Zhuhai Rundu Pharmaceutical Company Details
11.14.2 Zhuhai Rundu Pharmaceutical Business Overview
11.14.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Introduction
11.14.4 Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.14.5 Zhuhai Rundu Pharmaceutical Recent Development
11.15 Poly Pharm
11.15.1 Poly Pharm Company Details
11.15.2 Poly Pharm Business Overview
11.15.3 Poly Pharm Oral Voriconazole Introduction
11.15.4 Poly Pharm Revenue in Oral Voriconazole Business (2021–2026)
11.15.5 Poly Pharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Voriconazole Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Voriconazole Tablets
1.2.3 Voriconazole Capsules
1.2.4 Voriconazole Suspension
1.3 Market by Application
1.3.1 Global Oral Voriconazole Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Voriconazole Market Perspective (2021–2032)
2.2 Global Oral Voriconazole Growth Trends by Region
2.2.1 Global Oral Voriconazole Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oral Voriconazole Historic Market Size by Region (2021–2026)
2.2.3 Oral Voriconazole Forecasted Market Size by Region (2027–2032)
2.3 Oral Voriconazole Market Dynamics
2.3.1 Oral Voriconazole Industry Trends
2.3.2 Oral Voriconazole Market Drivers
2.3.3 Oral Voriconazole Market Challenges
2.3.4 Oral Voriconazole Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Voriconazole Players by Revenue
3.1.1 Global Top Oral Voriconazole Players by Revenue (2021–2026)
3.1.2 Global Oral Voriconazole Revenue Market Share by Players (2021–2026)
3.2 Global Top Oral Voriconazole Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oral Voriconazole Revenue
3.4 Global Oral Voriconazole Market Concentration Ratio
3.4.1 Global Oral Voriconazole Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Voriconazole Revenue in 2025
3.5 Global Key Players of Oral Voriconazole Head Offices and Areas Served
3.6 Global Key Players of Oral Voriconazole, Products and Applications
3.7 Global Key Players of Oral Voriconazole, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oral Voriconazole Breakdown Data by Type
4.1 Global Oral Voriconazole Historic Market Size by Type (2021–2026)
4.2 Global Oral Voriconazole Forecasted Market Size by Type (2027–2032)
5 Oral Voriconazole Breakdown Data by Application
5.1 Global Oral Voriconazole Historic Market Size by Application (2021–2026)
5.2 Global Oral Voriconazole Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oral Voriconazole Market Size (2021–2032)
6.2 North America Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oral Voriconazole Market Size by Country (2021–2026)
6.4 North America Oral Voriconazole Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Voriconazole Market Size (2021–2032)
7.2 Europe Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oral Voriconazole Market Size by Country (2021–2026)
7.4 Europe Oral Voriconazole Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oral Voriconazole Market Size (2021–2032)
8.2 Asia-Pacific Oral Voriconazole Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oral Voriconazole Market Size by Region (2021–2026)
8.4 Asia-Pacific Oral Voriconazole Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oral Voriconazole Market Size (2021–2032)
9.2 Latin America Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oral Voriconazole Market Size by Country (2021–2026)
9.4 Latin America Oral Voriconazole Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Voriconazole Market Size (2021–2032)
10.2 Middle East & Africa Oral Voriconazole Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oral Voriconazole Market Size by Country (2021–2026)
10.4 Middle East & Africa Oral Voriconazole Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Oral Voriconazole Introduction
11.1.4 Pfizer Revenue in Oral Voriconazole Business (2021–2026)
11.1.5 Pfizer Recent Development
11.2 Sandoz
11.2.1 Sandoz Company Details
11.2.2 Sandoz Business Overview
11.2.3 Sandoz Oral Voriconazole Introduction
11.2.4 Sandoz Revenue in Oral Voriconazole Business (2021–2026)
11.2.5 Sandoz Recent Development
11.3 Sun Pharmaceutical
11.3.1 Sun Pharmaceutical Company Details
11.3.2 Sun Pharmaceutical Business Overview
11.3.3 Sun Pharmaceutical Oral Voriconazole Introduction
11.3.4 Sun Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.3.5 Sun Pharmaceutical Recent Development
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Oral Voriconazole Introduction
11.4.4 Teva Revenue in Oral Voriconazole Business (2021–2026)
11.4.5 Teva Recent Development
11.5 Taj Pharmaceuticals
11.5.1 Taj Pharmaceuticals Company Details
11.5.2 Taj Pharmaceuticals Business Overview
11.5.3 Taj Pharmaceuticals Oral Voriconazole Introduction
11.5.4 Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.5.5 Taj Pharmaceuticals Recent Development
11.6 SiNi Pharma
11.6.1 SiNi Pharma Company Details
11.6.2 SiNi Pharma Business Overview
11.6.3 SiNi Pharma Oral Voriconazole Introduction
11.6.4 SiNi Pharma Revenue in Oral Voriconazole Business (2021–2026)
11.6.5 SiNi Pharma Recent Development
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Company Details
11.7.2 Lupin Pharmaceuticals Business Overview
11.7.3 Lupin Pharmaceuticals Oral Voriconazole Introduction
11.7.4 Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.7.5 Lupin Pharmaceuticals Recent Development
11.8 Viona Pharmaceuticals
11.8.1 Viona Pharmaceuticals Company Details
11.8.2 Viona Pharmaceuticals Business Overview
11.8.3 Viona Pharmaceuticals Oral Voriconazole Introduction
11.8.4 Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.8.5 Viona Pharmaceuticals Recent Development
11.9 Yangzijiang Pharmaceutical Group
11.9.1 Yangzijiang Pharmaceutical Group Company Details
11.9.2 Yangzijiang Pharmaceutical Group Business Overview
11.9.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Introduction
11.9.4 Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2021–2026)
11.9.5 Yangzijiang Pharmaceutical Group Recent Development
11.10 Huahai Pharmaceutical
11.10.1 Huahai Pharmaceutical Company Details
11.10.2 Huahai Pharmaceutical Business Overview
11.10.3 Huahai Pharmaceutical Oral Voriconazole Introduction
11.10.4 Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.10.5 Huahai Pharmaceutical Recent Development
11.11 Beijing Genetech Pharmaceutical
11.11.1 Beijing Genetech Pharmaceutical Company Details
11.11.2 Beijing Genetech Pharmaceutical Business Overview
11.11.3 Beijing Genetech Pharmaceutical Oral Voriconazole Introduction
11.11.4 Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.11.5 Beijing Genetech Pharmaceutical Recent Development
11.12 Union-Bio science
11.12.1 Union-Bio science Company Details
11.12.2 Union-Bio science Business Overview
11.12.3 Union-Bio science Oral Voriconazole Introduction
11.12.4 Union-Bio science Revenue in Oral Voriconazole Business (2021–2026)
11.12.5 Union-Bio science Recent Development
11.13 Brilliant Pharmaceuticals
11.13.1 Brilliant Pharmaceuticals Company Details
11.13.2 Brilliant Pharmaceuticals Business Overview
11.13.3 Brilliant Pharmaceuticals Oral Voriconazole Introduction
11.13.4 Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2021–2026)
11.13.5 Brilliant Pharmaceuticals Recent Development
11.14 Zhuhai Rundu Pharmaceutical
11.14.1 Zhuhai Rundu Pharmaceutical Company Details
11.14.2 Zhuhai Rundu Pharmaceutical Business Overview
11.14.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Introduction
11.14.4 Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2021–2026)
11.14.5 Zhuhai Rundu Pharmaceutical Recent Development
11.15 Poly Pharm
11.15.1 Poly Pharm Company Details
11.15.2 Poly Pharm Business Overview
11.15.3 Poly Pharm Oral Voriconazole Introduction
11.15.4 Poly Pharm Revenue in Oral Voriconazole Business (2021–2026)
11.15.5 Poly Pharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oral Voriconazole Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Voriconazole Tablets
Table 3. Key Players of Voriconazole Capsules
Table 4. Key Players of Voriconazole Suspension
Table 5. Global Oral Voriconazole Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Oral Voriconazole Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Oral Voriconazole Market Size by Region (US$ Million), 2021–2026
Table 8. Global Oral Voriconazole Market Share by Region (2021–2026)
Table 9. Global Oral Voriconazole Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Oral Voriconazole Market Share by Region (2027–2032)
Table 11. Oral Voriconazole Market Trends
Table 12. Oral Voriconazole Market Drivers
Table 13. Oral Voriconazole Market Challenges
Table 14. Oral Voriconazole Market Restraints
Table 15. Global Oral Voriconazole Revenue by Players (US$ Million), 2021–2026
Table 16. Global Oral Voriconazole Market Share by Players (2021–2026)
Table 17. Global Top Oral Voriconazole Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oral Voriconazole Revenue, 2025
Table 18. Ranking of Global Top Oral Voriconazole Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Oral Voriconazole Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Oral Voriconazole, Headquarters and Area Served
Table 21. Global Key Players of Oral Voriconazole, Products and Applications
Table 22. Global Key Players of Oral Voriconazole, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Oral Voriconazole Market Size by Type (US$ Million), 2021–2026
Table 25. Global Oral Voriconazole Revenue Market Share by Type (2021–2026)
Table 26. Global Oral Voriconazole Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Oral Voriconazole Revenue Market Share by Type (2027–2032)
Table 28. Global Oral Voriconazole Market Size by Application (US$ Million), 2021–2026
Table 29. Global Oral Voriconazole Revenue Market Share by Application (2021–2026)
Table 30. Global Oral Voriconazole Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Oral Voriconazole Revenue Market Share by Application (2027–2032)
Table 32. North America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 34. North America Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Oral Voriconazole Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Oral Voriconazole Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Oral Voriconazole Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Oral Voriconazole Product
Table 50. Pfizer Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 51. Pfizer Recent Development
Table 52. Sandoz Company Details
Table 53. Sandoz Business Overview
Table 54. Sandoz Oral Voriconazole Product
Table 55. Sandoz Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 56. Sandoz Recent Development
Table 57. Sun Pharmaceutical Company Details
Table 58. Sun Pharmaceutical Business Overview
Table 59. Sun Pharmaceutical Oral Voriconazole Product
Table 60. Sun Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 61. Sun Pharmaceutical Recent Development
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva Oral Voriconazole Product
Table 65. Teva Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 66. Teva Recent Development
Table 67. Taj Pharmaceuticals Company Details
Table 68. Taj Pharmaceuticals Business Overview
Table 69. Taj Pharmaceuticals Oral Voriconazole Product
Table 70. Taj Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 71. Taj Pharmaceuticals Recent Development
Table 72. SiNi Pharma Company Details
Table 73. SiNi Pharma Business Overview
Table 74. SiNi Pharma Oral Voriconazole Product
Table 75. SiNi Pharma Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 76. SiNi Pharma Recent Development
Table 77. Lupin Pharmaceuticals Company Details
Table 78. Lupin Pharmaceuticals Business Overview
Table 79. Lupin Pharmaceuticals Oral Voriconazole Product
Table 80. Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 81. Lupin Pharmaceuticals Recent Development
Table 82. Viona Pharmaceuticals Company Details
Table 83. Viona Pharmaceuticals Business Overview
Table 84. Viona Pharmaceuticals Oral Voriconazole Product
Table 85. Viona Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 86. Viona Pharmaceuticals Recent Development
Table 87. Yangzijiang Pharmaceutical Group Company Details
Table 88. Yangzijiang Pharmaceutical Group Business Overview
Table 89. Yangzijiang Pharmaceutical Group Oral Voriconazole Product
Table 90. Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 91. Yangzijiang Pharmaceutical Group Recent Development
Table 92. Huahai Pharmaceutical Company Details
Table 93. Huahai Pharmaceutical Business Overview
Table 94. Huahai Pharmaceutical Oral Voriconazole Product
Table 95. Huahai Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 96. Huahai Pharmaceutical Recent Development
Table 97. Beijing Genetech Pharmaceutical Company Details
Table 98. Beijing Genetech Pharmaceutical Business Overview
Table 99. Beijing Genetech Pharmaceutical Oral Voriconazole Product
Table 100. Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 101. Beijing Genetech Pharmaceutical Recent Development
Table 102. Union-Bio science Company Details
Table 103. Union-Bio science Business Overview
Table 104. Union-Bio science Oral Voriconazole Product
Table 105. Union-Bio science Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 106. Union-Bio science Recent Development
Table 107. Brilliant Pharmaceuticals Company Details
Table 108. Brilliant Pharmaceuticals Business Overview
Table 109. Brilliant Pharmaceuticals Oral Voriconazole Product
Table 110. Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 111. Brilliant Pharmaceuticals Recent Development
Table 112. Zhuhai Rundu Pharmaceutical Company Details
Table 113. Zhuhai Rundu Pharmaceutical Business Overview
Table 114. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product
Table 115. Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 116. Zhuhai Rundu Pharmaceutical Recent Development
Table 117. Poly Pharm Company Details
Table 118. Poly Pharm Business Overview
Table 119. Poly Pharm Oral Voriconazole Product
Table 120. Poly Pharm Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 121. Poly Pharm Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Oral Voriconazole Picture
Figure 2. Global Oral Voriconazole Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Oral Voriconazole Market Share by Type: 2025 vs 2032
Figure 4. Voriconazole Tablets Features
Figure 5. Voriconazole Capsules Features
Figure 6. Voriconazole Suspension Features
Figure 7. Global Oral Voriconazole Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Oral Voriconazole Market Share by Application: 2025 vs 2032
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Oral Voriconazole Report Years Considered
Figure 12. Global Oral Voriconazole Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Oral Voriconazole Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oral Voriconazole Market Share by Region: 2025 vs 2032
Figure 15. Global Oral Voriconazole Market Share by Players in 2025
Figure 16. Global Oral Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oral Voriconazole Revenue in 2025
Figure 18. North America Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Oral Voriconazole Market Share by Country (2021–2032)
Figure 20. United States Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Oral Voriconazole Market Share by Country (2021–2032)
Figure 24. Germany Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Oral Voriconazole Market Share by Region (2021–2032)
Figure 32. China Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Oral Voriconazole Market Share by Country (2021–2032)
Figure 40. Mexico Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Oral Voriconazole Market Share by Country (2021–2032)
Figure 44. Israel Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Pfizer Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 48. Sandoz Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 50. Teva Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 51. Taj Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 52. SiNi Pharma Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 53. Lupin Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 54. Viona Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 55. Yangzijiang Pharmaceutical Group Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 56. Huahai Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 57. Beijing Genetech Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 58. Union-Bio science Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 59. Brilliant Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 60. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 61. Poly Pharm Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Oral Voriconazole Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Voriconazole Tablets
Table 3. Key Players of Voriconazole Capsules
Table 4. Key Players of Voriconazole Suspension
Table 5. Global Oral Voriconazole Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Oral Voriconazole Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Oral Voriconazole Market Size by Region (US$ Million), 2021–2026
Table 8. Global Oral Voriconazole Market Share by Region (2021–2026)
Table 9. Global Oral Voriconazole Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Oral Voriconazole Market Share by Region (2027–2032)
Table 11. Oral Voriconazole Market Trends
Table 12. Oral Voriconazole Market Drivers
Table 13. Oral Voriconazole Market Challenges
Table 14. Oral Voriconazole Market Restraints
Table 15. Global Oral Voriconazole Revenue by Players (US$ Million), 2021–2026
Table 16. Global Oral Voriconazole Market Share by Players (2021–2026)
Table 17. Global Top Oral Voriconazole Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oral Voriconazole Revenue, 2025
Table 18. Ranking of Global Top Oral Voriconazole Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Oral Voriconazole Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Oral Voriconazole, Headquarters and Area Served
Table 21. Global Key Players of Oral Voriconazole, Products and Applications
Table 22. Global Key Players of Oral Voriconazole, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Oral Voriconazole Market Size by Type (US$ Million), 2021–2026
Table 25. Global Oral Voriconazole Revenue Market Share by Type (2021–2026)
Table 26. Global Oral Voriconazole Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Oral Voriconazole Revenue Market Share by Type (2027–2032)
Table 28. Global Oral Voriconazole Market Size by Application (US$ Million), 2021–2026
Table 29. Global Oral Voriconazole Revenue Market Share by Application (2021–2026)
Table 30. Global Oral Voriconazole Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Oral Voriconazole Revenue Market Share by Application (2027–2032)
Table 32. North America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 34. North America Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Oral Voriconazole Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Oral Voriconazole Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Oral Voriconazole Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Oral Voriconazole Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Oral Voriconazole Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Oral Voriconazole Market Size by Country (US$ Million), 2027–2032
Table 47. Pfizer Company Details
Table 48. Pfizer Business Overview
Table 49. Pfizer Oral Voriconazole Product
Table 50. Pfizer Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 51. Pfizer Recent Development
Table 52. Sandoz Company Details
Table 53. Sandoz Business Overview
Table 54. Sandoz Oral Voriconazole Product
Table 55. Sandoz Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 56. Sandoz Recent Development
Table 57. Sun Pharmaceutical Company Details
Table 58. Sun Pharmaceutical Business Overview
Table 59. Sun Pharmaceutical Oral Voriconazole Product
Table 60. Sun Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 61. Sun Pharmaceutical Recent Development
Table 62. Teva Company Details
Table 63. Teva Business Overview
Table 64. Teva Oral Voriconazole Product
Table 65. Teva Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 66. Teva Recent Development
Table 67. Taj Pharmaceuticals Company Details
Table 68. Taj Pharmaceuticals Business Overview
Table 69. Taj Pharmaceuticals Oral Voriconazole Product
Table 70. Taj Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 71. Taj Pharmaceuticals Recent Development
Table 72. SiNi Pharma Company Details
Table 73. SiNi Pharma Business Overview
Table 74. SiNi Pharma Oral Voriconazole Product
Table 75. SiNi Pharma Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 76. SiNi Pharma Recent Development
Table 77. Lupin Pharmaceuticals Company Details
Table 78. Lupin Pharmaceuticals Business Overview
Table 79. Lupin Pharmaceuticals Oral Voriconazole Product
Table 80. Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 81. Lupin Pharmaceuticals Recent Development
Table 82. Viona Pharmaceuticals Company Details
Table 83. Viona Pharmaceuticals Business Overview
Table 84. Viona Pharmaceuticals Oral Voriconazole Product
Table 85. Viona Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 86. Viona Pharmaceuticals Recent Development
Table 87. Yangzijiang Pharmaceutical Group Company Details
Table 88. Yangzijiang Pharmaceutical Group Business Overview
Table 89. Yangzijiang Pharmaceutical Group Oral Voriconazole Product
Table 90. Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 91. Yangzijiang Pharmaceutical Group Recent Development
Table 92. Huahai Pharmaceutical Company Details
Table 93. Huahai Pharmaceutical Business Overview
Table 94. Huahai Pharmaceutical Oral Voriconazole Product
Table 95. Huahai Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 96. Huahai Pharmaceutical Recent Development
Table 97. Beijing Genetech Pharmaceutical Company Details
Table 98. Beijing Genetech Pharmaceutical Business Overview
Table 99. Beijing Genetech Pharmaceutical Oral Voriconazole Product
Table 100. Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 101. Beijing Genetech Pharmaceutical Recent Development
Table 102. Union-Bio science Company Details
Table 103. Union-Bio science Business Overview
Table 104. Union-Bio science Oral Voriconazole Product
Table 105. Union-Bio science Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 106. Union-Bio science Recent Development
Table 107. Brilliant Pharmaceuticals Company Details
Table 108. Brilliant Pharmaceuticals Business Overview
Table 109. Brilliant Pharmaceuticals Oral Voriconazole Product
Table 110. Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 111. Brilliant Pharmaceuticals Recent Development
Table 112. Zhuhai Rundu Pharmaceutical Company Details
Table 113. Zhuhai Rundu Pharmaceutical Business Overview
Table 114. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product
Table 115. Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 116. Zhuhai Rundu Pharmaceutical Recent Development
Table 117. Poly Pharm Company Details
Table 118. Poly Pharm Business Overview
Table 119. Poly Pharm Oral Voriconazole Product
Table 120. Poly Pharm Revenue in Oral Voriconazole Business (US$ Million), 2021–2026
Table 121. Poly Pharm Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Oral Voriconazole Picture
Figure 2. Global Oral Voriconazole Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Oral Voriconazole Market Share by Type: 2025 vs 2032
Figure 4. Voriconazole Tablets Features
Figure 5. Voriconazole Capsules Features
Figure 6. Voriconazole Suspension Features
Figure 7. Global Oral Voriconazole Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Oral Voriconazole Market Share by Application: 2025 vs 2032
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Oral Voriconazole Report Years Considered
Figure 12. Global Oral Voriconazole Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Oral Voriconazole Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Oral Voriconazole Market Share by Region: 2025 vs 2032
Figure 15. Global Oral Voriconazole Market Share by Players in 2025
Figure 16. Global Oral Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Oral Voriconazole Revenue in 2025
Figure 18. North America Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Oral Voriconazole Market Share by Country (2021–2032)
Figure 20. United States Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Oral Voriconazole Market Share by Country (2021–2032)
Figure 24. Germany Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Oral Voriconazole Market Share by Region (2021–2032)
Figure 32. China Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Oral Voriconazole Market Share by Country (2021–2032)
Figure 40. Mexico Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Oral Voriconazole Market Share by Country (2021–2032)
Figure 44. Israel Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Oral Voriconazole Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Pfizer Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 48. Sandoz Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 49. Sun Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 50. Teva Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 51. Taj Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 52. SiNi Pharma Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 53. Lupin Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 54. Viona Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 55. Yangzijiang Pharmaceutical Group Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 56. Huahai Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 57. Beijing Genetech Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 58. Union-Bio science Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 59. Brilliant Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 60. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 61. Poly Pharm Revenue Growth Rate in Oral Voriconazole Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232